Abstract.-The effect of antibiotics on the binding of phenylalanyl-oligonucleotide to ribosomes has been examined. The results show that many classes of antibiotics can interfere with binding of the aminoacyl-oligonucleotide terminus of tRNA to ribosomes: chloramphenicol, sparsomycin, D-WIN-5094, vernamycin A, PA114A, streptogramin, amicetin, gougerotin, tylosin, and spiramycin II1.
The binding of phenylalanyl-oligonucleotides (Phe-oligonucleotide) to ribosomes has recently been reported from this laboratory1' 2 (Fig. 1) . The binding of this terminal T, ribonuclease fragment of aminoacyl-tRNA to ribosomes enables one to distinguish between two events involving peptide bond formation ( Fig. 2) : the binding of the peptidyl-or aminoacyl-tRNA terminus (pCpCpA end) to ribosomes (Steps 1 and 2, respectively) and the subsequent transfer of the nascent peptide to the adjacent aminoacyl-tRNA to form a peptide bond (peptidyl transfer reaction, Step 3) .
Studies of the peptidyl transfer reaction3' have generally involved assay of the end product of the reaction rather than the individual steps. The reaction of peptidyl-tRNA,3-5 fMet-tRNA,7 8 or N-acetyl-Phe-tRNA9' 10 with puromycin has been used as an analog of peptide bond formation and is the result of both events. Thus, requirements of formation of the puromycin product characterize the overall reaction rather than the peptidyl transfer reaction itself (Step 3). When the binding of Phe-oligonucleotide to ribosomes was examined, its characteristics and requirements resembled those usually ascribed to the peptidyltransferase step." 2 Mlany antibiotics have been shown to influence the overall reaction.3-5 10-17 In fact, we recently showed that chloramphenicol was a competitive inhibitor of puromycin in the overall reaction.'8 In order to localize further their site of action it was, therefore, necessary to determine if chloramphenicol and other antibiotics could influence the binding of Phe-oligonucleotide to ribosomes. In this report, we have, therefore, examined the effect of antibiotics on the binding of Phe-oligonucleotide to ribosomes.
Experimental Procedure. Step 1 represents the binding of the CCA-terminus of peptidyl-tRNA to ribosomes (RIB), namely, the binding of CAACCA-fMet to ribosomes.
Step 2 represents the binding of puromycin to the ribosome, which is equivalent to the binding of the CCA-terminus of aminoacyl-tRNA and Phe-oligonucleotide to ribosomes.
Step 3 represents the peptidyl-transfer reaction, with the resultant formation of a peptide bond.
Results and Discussion.-The results (Table 1) indicate that several different groups of antibiotics significantly affect the binding of Phe-oligonucleotide to ribosomes. Chloramphenicol, sparsomycin, and D-WIN-5094 inhibit the binding of the Phe-oligonucleotide to ribosomes at 10-5 M. The streptogramin A group of antibiotics (streptogramin, vernamycin A, and PA114A) markedly inhibit the binding at 10-5 M. PA114B significantly stimulates the binding of Phe-oligo- nucleotide to ribosomes; this resembles its stimulation of aminoacyl-tRNA binding to ribosomes. 23 The pyrimidine antibiotics, amicetin and gougerotin, produce substantial inhibition. Two macrolide antibiotics, tylosin and spiramycin III, produced inhibition although erythromycin did not. Although edeine produced inhibition at 10-5 M, this inhibition of Phe-oligonucleotide binding to ribosomes was much smaller than its inhibition of Phe-tRNA binding to ribosomes at comparable concentrations.24 Tetracycline had an inhibitory effect at 10-4 M. Fusidic acid, bottromycin, aurintricarboxylic acid, pactamycin, and spectinomycin produced no evident inhibition of Phe-oligonucleotide binding to ribosomes.
The effects of chloramphenicol and sparsomycin concentration on Pheoligonucleotide binding to ribosomes are shown in Figures 3 and 4 , respectively. Chloramphenicol is markedly inhibitory to this binding at concentrations which inhibit protein synthesis in vivo.A5 26 Puromycin also inhibits Phe-oligonucleotide binding to ribosomes, but does not react with it to form phenylalanyl-puromycin (Fig. 5) .
The present results indicate that many antibiotics can interfere with the binding of the Phe-oligonucleotide to ribosomes and, therefore, probably interfere with functional attachment of the aminoacyl-end of tRNA to ribosomes. This may be the primary mode of action of chloramphenicol, sparsomycin, D-WIN-5094, vernamycin A, PA114A, streptogramin, amicetin, gougerotin, and perhaps of tylosin and spiramycin III. It may be a secondary effect for edeine, strepto-mycin, neomycin, and tetracycline produced by induction of conformational changes in the ribosome through their interaction with the 30S subunit.
Sparsomycin stimulates the binding of CACCA-Leu-Ac but not the unblocked CACCA-Leu to ribosomes.27 The Leu-Ac with ribosomes does not readily react with puromycin. It is possible that in the presence of sparsomycin the ribosome is fixed in a conformation which is unable to bind puromycin, Phe-oligonucleotide, or the aminoacyl-end of aminoacyl tRNA; but binds peptidyl-tRNA tightly. Chloramphenicol, spiramycin III, streptogramin A, amicetin, and gougerotin inhibit the binding of CACCA-Leu-Ac stimulated by sparsomycin.27 They may accomplish this by inhibiting the binding of sparsomycin to the ribosome or by interfering with the binding of CACCALeu-Ac itself. By studying the binding of N-acylated and unblocked aminoacyloligonucleotides to ribosomes it should be possible to clarify further the action of these antibiotics and the nature of the ribosomal sites. Also, it should be considered that the Phe-oligonucleotide may be binding to ribosomal sites other than those participating in peptide bond formation. The hypothesis that chloramphenicol inhibits protein synthesis by interfering with the binding of the aminoacyl-end of aminoacyl-tRNA to ribosomes is consistent with these results. It is possible that the binding of peptidyl-tRNA also may be inhibited by chloramphenicol. Coutsogeorgopoulos" suggested that chloramphenicol may compete with the aminoacyl-end of tRNA for binding to ribosomes. On the other hand, Das, Goldstein, and Kanner28 suggested that chloramphenicol may be an analog of the C-terminal amino acid of peptidyl-tRNA.
The present findings are consistent with and help to explain the varied effects of chloramphenicol on bacterial protein synthesis. The paradoxical observation that the inhibition of polypeptide synthesis is dependent on the template29' 30 is probably a function of the trichloroacetic acid precipitability of the various polypeptides synthesized rather than of any real influence of the template on chloramphenicol action. For although polylysine synthesis appears to be inhibited more than polyphenylalanine synthesis, analysis of the oligolysine products shows an increase of shorter chain-length material so that net peptide bond synthesis is only slightly inhibited.3' In the case of phenylalanine, where the short peptides are precipitable with trichloroacetic acid,32 there is thus a small difference in the presence and absence of chloramphenicol. Nevertheless, diphenylalanine synthesis is often stimulated while the production of longer chains is inhibited,'3 which is a finding consistent with the polylysine results.
Also, it should be noted that sparsomycin and chloramphenicol, antibiotics which inhibit termination,33 also inhibit Phe-oligonucleotide binding to ribosomes. It is, therefore, possible that these antibiotics inhibit termination by interfering with proper binding of the peptidyl-or aminoacyl-tRNA terminus to the ribosome rather than by inhibiting the synthesis of a labile peptide intermediate. Furthermore, it should be emphasized that the binding of aminoacyltRNA to ribosomes is probably a multistep process during which several portions of each tRNA molecule associate with specific areas of ribosomes in a defined temporal and spacial sequence with which many antibiotics may interfere.
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